ANI Pharmaceuticals Inc. (NASDAQ: ANIP) announced that results from its NEW DAY clinical trial for ILUVIEN have been published in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE